J Mov Disord.
2023 Sep;16(3):328-330. 10.14802/jmd.23057.
Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?
- Affiliations
-
- 1AP-HP, Salpetriere Hospital, DMU Neuroscience 6, Paris, France
- 2University Lille, Lille Neuroscience & Cognition, Team DVCD, INSERM UMRS_1172, CHU Lille, Department of Medical Pharmacology, Expert Center of Parkinson’s Disease, LICEND COEN Center, NS-Park/FCRIN Network, France
- 3Sorbonne University, Paris Brain Institute, INSERM, CNRS, Paris, France
- KMID: 2545930
- DOI: http://doi.org/10.14802/jmd.23057
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Significance of Apomorphine-Induced Rotational Behavior in Partial Lesioned Rat Parkinsonian Models with 6-hydroxydopamine
- Influence of the brain noradrenergic system on the rotational behavior induced by apomorphine in the substantia nigra-lesioned rat
- Hypersexuality Induced by Rasagiline Monotherapy in a Patinet with Parkinson's Disease
- Behavioral and Immunohistochemical Characterization of 6-Hydroxydopamine Induced Rat Models of Parkinson's Disease
- Expression of Dopamine D2 Receptor in Response to Apomorphine Treatment in the Striatum of the Rat with Experimentally Induced Parkinsonism
